Yousif Capital Management LLC Cuts Stock Position in Amedisys, Inc. (NASDAQ:AMED)

Yousif Capital Management LLC lessened its holdings in Amedisys, Inc. (NASDAQ:AMED) by 4.6% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 11,834 shares of the health services provider’s stock after selling 569 shares during the period. Yousif Capital Management LLC’s holdings in Amedisys were worth $1,074,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of the business. Blue Trust Inc. increased its stake in Amedisys by 55.1% in the 4th quarter. Blue Trust Inc. now owns 349 shares of the health services provider’s stock worth $34,000 after buying an additional 124 shares in the last quarter. Inspire Investing LLC increased its stake in Amedisys by 3.6% in the 4th quarter. Inspire Investing LLC now owns 4,405 shares of the health services provider’s stock worth $400,000 after buying an additional 155 shares in the last quarter. Nisa Investment Advisors LLC boosted its holdings in shares of Amedisys by 1.2% during the 4th quarter. Nisa Investment Advisors LLC now owns 15,150 shares of the health services provider’s stock valued at $1,375,000 after purchasing an additional 180 shares during the last quarter. Retirement Systems of Alabama boosted its holdings in shares of Amedisys by 0.5% during the 4th quarter. Retirement Systems of Alabama now owns 39,822 shares of the health services provider’s stock valued at $3,615,000 after purchasing an additional 181 shares during the last quarter. Finally, Versant Capital Management Inc boosted its holdings in shares of Amedisys by 68.5% during the 4th quarter. Versant Capital Management Inc now owns 450 shares of the health services provider’s stock valued at $41,000 after purchasing an additional 183 shares during the last quarter. Hedge funds and other institutional investors own 94.36% of the company’s stock.

Amedisys Stock Down 0.2 %

Shares of NASDAQ:AMED opened at $92.60 on Friday. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05. Amedisys, Inc. has a 12 month low of $82.15 and a 12 month high of $98.95. The company has a 50-day moving average price of $90.11 and a 200 day moving average price of $93.64. The company has a market cap of $3.03 billion, a price-to-earnings ratio of 36.75, a PEG ratio of 1.82 and a beta of 0.73.

Wall Street Analyst Weigh In

Separately, Stephens reissued an “equal weight” rating and set a $101.00 price objective on shares of Amedisys in a report on Wednesday. Five equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $100.75.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.